RxDoctor Payments Data

Peter Pons, MD

Vascular Surgery · Florence, ALNPI 1205814019

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,280 of the $53,888 with a category attached, or 84.0%. Cook Incorporated accounts for 93.8% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $15,066 and has fallen 54.3% since, to $6,883 in 2025. Among vascular surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$53,888in general payments, 2019–2025

Across 145 payments — averaging $371.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$51K
  • Cook Medical LLC$619
  • Endologix LLC$449
  • Abiomed$361
  • Penumbra, Inc.$335
  • Bard Peripheral Vascular, Inc.$325
  • plus $1K from 21 others
$20,712in research payments, 2019–2025

Across 3 payments — averaging $6904.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$21K

What the payments were for

  • Consulting fees$5,28010%
  • Speaking & faculty fees$45,28084%
  • Food & beverage$3,3286%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$53,888 in reported general payments places this provider in the 95th percentile of 61 vascular surgery providers in Alabama.

See all vascular surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$157,048
Medicare patients
313
Services billed
828

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor112$62,066
EliquisApixaban80$51,818
ClopidogrelClopidogrel Bisulfate311$1,965
Prasugrel Hcl45$1,341
Cilostazol39$1,013
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$246
Warfarin Sodium11$99

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Florence

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →